Type D personality, self-efficacy, and medication adherence following an acute coronary syndrome

Gerard J Molloy1, Gemma Randall, Anna Wikman

  • 1Division of Psychology, School of Natural Sciences, Cottrell Bldg, University of Stirling, Stirling FK9 4LA, Scotland. g.j.molloy@stir.ac.uk

Psychosomatic Medicine
|December 14, 2011
PubMed

Insights

Negative affectivity, a component of Type D personality, is linked to poorer medication adherence in heart disease patients, potentially mediated by lower self-efficacy. This highlights the importance of addressing negative emotions for better treatment outcomes.

Area of Science:

  • Cardiology
  • Psychology
  • Health Behavior

Background:

  • Coronary heart disease (CHD) patients often struggle with medication adherence.
  • Type D personality, characterized by negative affectivity and social inhibition, is prevalent in CHD populations.
  • Self-efficacy plays a crucial role in managing chronic illnesses like CHD.

Purpose of the Study:

  • To investigate the relationship between Type D personality, self-efficacy, and medication adherence in CHD patients.
  • To determine if self-efficacy mediates the association between Type D personality traits and medication adherence.

Main Methods:

  • Prospective observational study of 165 patients hospitalized for acute coronary syndrome.
  • Assessment of Type D personality, self-efficacy, and medication adherence at 3 weeks post-hospitalization.
  • Follow-up medication adherence measurement at 6 months using self-report; statistical analyses included multiple linear regression and mediation analysis.

Main Results:

  • 30% of patients exhibited Type D personality.
  • Type D personality was associated with significantly poorer medication adherence at 6 months.
  • Negative affectivity, a component of Type D personality, was independently associated with poorer adherence, partly mediated by lower self-efficacy.

Conclusions:

  • Negative affectivity, rather than the full Type D construct, appears more critical in predicting medication adherence in CHD.
  • Lower self-efficacy may explain the link between higher negative affectivity and reduced medication adherence.
  • Interventions targeting negative affectivity and enhancing self-efficacy could improve medication adherence in CHD patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Stress Prevention and Stress Management Techniques I01:26

Stress Prevention and Stress Management Techniques I

Stress prevention and management are crucial for maintaining well-being and building resilience. Techniques to manage stress include cultivating qualities like conscientiousness, a sense of personal control, and self-efficacy. Each of these traits significantly reduces stress and promotes healthier lifestyle choices and outcomes.
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...